US 12,077,607 B2
Functional and therapeutic effects of PAR4 cleavage by cathepsin G
Paul F. Bray, Salt Lake City, UT (US); Robert A. Campbell, Salt Lake City, UT (US); and Michelle Stoller, Salt Lake City, UT (US)
Assigned to UNIVERSITY OF UTAH RESEARCH FOUNDATION, Salt Lake City, UT (US)
Filed by UNIVERSITY OF UTAH RESEARCH FOUNDATION, Salt Lake City, UT (US)
Filed on Sep. 23, 2022, as Appl. No. 17/934,816.
Claims priority of provisional application 63/247,636, filed on Sep. 23, 2021.
Prior Publication US 2023/0126796 A1, Apr. 27, 2023
Int. Cl.
C07K 7/06
(2006.01);
A61P 7/04
(2006.01);
A61K 38/00
(2006.01)
CPC
C07K 7/06
(2013.01) [
A61P 7/04
(2018.01);
A61K 38/00
(2013.01)]
13 Claims
1. A synthetic peptide mimetic consisting of SEQ ID NO: 1, wherein the synthetic peptide mimetic induces activation of and signaling through PAR4.